We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmakers Call for FDA Oversight of Laboratory Developed COVID-19 Tests
Lawmakers Call for FDA Oversight of Laboratory Developed COVID-19 Tests
Several House Democrats have urged the Department of Health and Human Services (HHS) to reverse a Trump administration policy that removed FDA premarket review requirements for COVID-19 laboratory-developed tests (LDTs).
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor